Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function

Chen,Liangyu; Li,Xinxing; Liu,Libo; Yu,Bo; Xue,Yixue; Liu,Yunhui

doi:10.3892/or.2015.3712

Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function

Authors:
- Liangyu Chen
- Xinxing Li
- Libo Liu
- Bo Yu
- Yixue Xue
- Yunhui Liu
View Affiliations

Affiliations: Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, P.R. China, Department of Neurobiology, College of Basic Medicine, China Medical University, Shenyang, Liaoning, P.R. China
Published online on: January 13, 2015 https://doi.org/10.3892/or.2015.3712
Pages: 1465-1474

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Glioblastoma multiforme (GBM) is one of the most common encephalic malignant tumors. Due to a high recurrence rate and a lack of effective treatments, the average survival rate remains low. Temozolomide (TMZ), a class of alkylating agent, is widely used as a first-line therapeutic drug during the adjuvant treatment for GBM patients. However, most patients exhibit a palpable resistance to TMZ treatment. Additionally, the underlying mechanism remains to be clarified. In this study, glutathione (GSH) and reactive oxygen species (ROS) levels were found to be closely associated with the sensitivity of GBM cells to TMZ. We also found that TMZ markedly induced xCT, the subunit of glutamate/cystine transporter system xc- expression, which together with the GSH synthesis was increased while the TMZ-inducible ROS level was decreased in GBM cells. In addition, the cystathionine γ-lyase (CTH) acivity, a key enzyme in the transsulfuration pathway was enhanced by TMZ, which insured a cysteine supply and GSH synthesis in a compensatory manner when xCT was blocked. Thus, the individual inhibition of xCT by siRNA and a pharmacological inhibitor (sulfasalazine) only partially inhibited GSH synthesis and moderately enhanced the GBM cell sensitivity to TMZ. However, the TMZ‑induced cytotoxicity was markedly increased along with a marked decrease in GSH levels as result of co-treatment with erastin, which inhibited cysteine uptake from xCT transporter and suppressed CTH activity, leading to impaired transformation from methionine to cysteine. In conclusion, to GBM therapy with a drug combination of TMZ and erastin may be beneficial.

View Figures

View References

1	Friedman HS, Kerby T and Calvert H: Temozolomide and treatment of malignant glioma. Clin Cancer Res. 6:2585–2597. 2000.PubMed/NCBI
2	Gunther W, Pawlak E, Damasceno R, Arnold H and Terzis AJ: Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids. Br J Cancer. 88:463–469. 2003. View Article : Google Scholar : PubMed/NCBI
3	Knauth M, Wirtz CR, Tronnier VM, Aras N, Kunze S and Sartor K: Intraoperative MR imaging increases the extent of tumor resection in patients with high-grade gliomas. AJNR Am J Neuroradiol. 20:1642–1646. 1999.PubMed/NCBI
4	Nakada M, Nakada S, Demuth T, Tran NL, Hoelzinger DB and Berens ME: Molecular targets of glioma invasion. Cell Mol Life Sci. 64:458–478. 2007. View Article : Google Scholar : PubMed/NCBI
5	Stupp R, Mason WP, van den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
6	Burnet NG, Jefferies SJ, Benson RJ, Hunt DP and Treasure FP: Years of life lost (YLL) from cancer is an important measure of population burden - and should be considered when allocating research funds. Br J Cancer. 92:241–245. 2005.PubMed/NCBI
7	Bocangel DB, Finkelstein S, Schold SC, Bhakat KK, Mitra S and Kokkinakis DM: Multifaceted resistance of gliomas to temozolomide. Clin Cancer Res. 8:2725–2734. 2002.PubMed/NCBI
8	Hegi ME, Diserens A, Gorlia T, et al: MGMT gene silencing and benefit from temozolomide in glioblastoma. New Engl J Med. 352:997–1003. 2005. View Article : Google Scholar : PubMed/NCBI
9	Conrad M and Sato H: The oxidative stress-inducible cystine/glutamate antiporter, system x (c) (−): cystine supplier and beyond. Amino Acids. 42:231–246. 2012. View Article : Google Scholar
10	Sato H, Tamba M, Ishii T and Bannai S: Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J Biol Chem. 274:11455–11458. 1999. View Article : Google Scholar : PubMed/NCBI
11	Okuno S, Sato H, Kuriyama-Matsumura K, et al: Role of cystine transport in intracellular glutathione level and cisplatin resistance in human ovarian cancer cell lines. Br J Cancer. 88:951–956. 2003. View Article : Google Scholar : PubMed/NCBI
12	Lu SC: Glutathione synthesis. Biochim Biophys Acta. 1830:3143–3153. 2013. View Article : Google Scholar :
13	Ye P, Mimura J, Okada T, et al: Nrf2- and ATF4-dependent up-regulation of xCT modulates the sensitivity of T24 bladder carcinoma cells to proteasome inhibition. Mol Cell Biol. 34:3421–3434. 2014. View Article : Google Scholar : PubMed/NCBI
14	Toyoda M, Kaira K, Ohshima Y, et al: Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer. Br J Cancer. 110:2506–2513. 2014. View Article : Google Scholar : PubMed/NCBI
15	Yoshikawa M, Tsuchihashi K, Ishimoto T, et al: xCT inhibition depletes CD44v-expressing tumor cells that are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma. Cancer Res. 73:1855–1866. 2013. View Article : Google Scholar : PubMed/NCBI
16	Guo W, Zhao Y, Zhang Z, et al: Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma. Cancer Lett. 312:55–61. 2011. View Article : Google Scholar : PubMed/NCBI
17	Chen RS, Song YM, Zhou ZY, et al: Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/beta-catenin pathway. Oncogene. 28:599–609. 2009. View Article : Google Scholar
18	Gout PW, Buckley AR, Simms CR and Bruchovsky N: Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug. Leukemia. 15:1633–1640. 2001. View Article : Google Scholar : PubMed/NCBI
19	Robe PA, Martin DH, Nguyen-Khac MT, et al: Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of sulfasalazine for the treatment of progressing malignant gliomas in adults. BMC Cancer. 9:3722009. View Article : Google Scholar : PubMed/NCBI
20	Takeuchi S, Wada K, Nagatani K, Otani N, Osada H and Nawashiro H: Sulfasalazine and temozolomide with radiation therapy for newly diagnosed glioblastoma. Neurol India. 62:42–47. 2014. View Article : Google Scholar : PubMed/NCBI
21	Yagoda N, von Rechenberg M, Zaganjor E, et al: RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature. 447:864–868. 2007. View Article : Google Scholar : PubMed/NCBI
22	Dixon SJ, Lemberg KM, Lamprecht MR, et al: Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 149:1060–1072. PubMed/NCBI
23	Yang WS, SriRamaratnam R, Welsch ME, et al: Regulation of ferroptotic cancer cell death by GPX4. Cell. 156:317–331. 2014. View Article : Google Scholar : PubMed/NCBI
24	Giordana L, Mantilla BS, Santana M, Silber AM and Nowicki C: Cystathionine γ-lyase, an enzyme related to the reverse transsulfuration pathway, is functional in Leishmania spp. J Eukaryot Microbiol. 61:204–213. 2014. View Article : Google Scholar : PubMed/NCBI
25	Romero I, Téllez J, Yamanaka LE, Steindel M, Romanha AJ and Grisard EC: Transsulfuration is an active pathway for cysteine biosynthesis in Trypanosoma rangeli. Parasit Vectors. 7:1972014. View Article : Google Scholar : PubMed/NCBI
26	McBean GJ: The transsulfuration pathway: a source of cysteine for glutathione in astrocytes. Amino Acids. 42:199–205. 2012. View Article : Google Scholar
27	Manna P and Jain SK: Vitamin D up-regulates glucose transporter 4 (GLUT4) translocation and glucose utilization mediated by cystathionine-gamma-lyase (CSE) activation and H2S formation in 3T3L1 adipocytes. J Biol Chem. 287:42324–42332. 2012. View Article : Google Scholar : PubMed/NCBI
28	Rao AM, Drake MR and Stipanuk MH: Role of the transsulfuration pathway and of gamma-cystathionase activity in the formation of cysteine and sulfate from methionine in rat hepatocytes. J Nutr. 120:837–845. 1990.PubMed/NCBI
29	Liu G, Casqueiro J, Bañuelos O, Cardoza RE, Gutiérrez S and Martín JF: Targeted inactivation of the mecB gene, encoding cystathionine-gamma-lyase, shows that the reverse transsulfuration pathway is required for high-level cephalosporin biosynthesis in Acremonium chrysogenum C10 but not for methionine induction of the cephalosporin genes. J Bacteriol. 183:1765–1772. 2001. View Article : Google Scholar : PubMed/NCBI
30	Yang G, Cao K, Wu L and Wang R: Cystathionine gamma-lyase overexpression inhibits cell proliferation via a H2S-dependent modulation of ERK1/2 phosphorylation and p21Cip/WAK-1. J Biol Chem. 279:49199–49205. 2004. View Article : Google Scholar : PubMed/NCBI
31	Sasaki H, Sato H, Kuriyama-Matsumura K, et al: Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J Biol Chem. 277:44765–44771. 2002. View Article : Google Scholar : PubMed/NCBI
32	Wu G, Fang YZ, Yang S, Lupton JR and Turner ND: Glutathione metabolism and its implications for health. J Nutr. 134:489–492. 2004.PubMed/NCBI
33	Chung WJ and Sontheimer H: Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor-kappaB. J Neurochem. 110:182–193. 2009. View Article : Google Scholar : PubMed/NCBI
34	Kandil S, Brennan L and McBean GJ: Glutathione depletion causes a JNK and p38MAPK-mediated increase in expression of cystathionine-gamma-lyase and upregulation of the transsulfuration pathway in C6 glioma cells. Neurochem Int. 56:611–619. 2010. View Article : Google Scholar : PubMed/NCBI
35	Hottinger AF, Aissa AB, Espeli V, et al: Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma. Br J Cancer. 110:2655–2661. 2014. View Article : Google Scholar : PubMed/NCBI
36	Bartels U, Wolff J, Gore L, et al: Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma. Neuro Oncol. 16:1554–1559. 2014. View Article : Google Scholar : PubMed/NCBI
37	Margison GP and Santibanez-Koref MF: O6-alkylguanine-DNA alkyltransferase: role in carcinogenesis and chemotherapy. Bioessays. 24:255–266. 2002. View Article : Google Scholar : PubMed/NCBI
38	Zhang J, Stevens MF and Bradshaw TD: Temozolomide: mechanisms of action, repair and resistance. Curr Mol Pharmacol. 5:102–114. 2012. View Article : Google Scholar
39	She X, Yu Z, Cui Y, et al: miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma. Oncol Rep. 32:957–964. 2014.PubMed/NCBI
40	Lin CJ, Lee CC, Shih YL, et al: Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy. Free Radic Biol Med. 52:377–391. 2012. View Article : Google Scholar
41	Yin H, Zhou Y, Wen C, et al: Curcumin sensitizes glioblastoma to temozolomide by simultaneously generating ROS and disrupting AKT/mTOR signaling. Oncol Rep. 32:1610–1616. 2014.PubMed/NCBI
42	Dai L, Cao Y, Chen Y, Parsons C and Qin Z: Targeting xCT, a cystine-glutamate transporter induces apoptosis and tumor regression for KSHV/HIV-associated lymphoma. J Hematol Oncol. 7:302014. View Article : Google Scholar : PubMed/NCBI
43	Doxsee DW, Gout PW, Kurita T, et al: Sulfasalazine-induced cystine starvation: potential use for prostate cancer therapy. Prostate. 67:162–171. 2007. View Article : Google Scholar
44	Ehren JL and Maher P: Concurrent regulation of the transcription factors Nrf2 and ATF4 mediates the enhancement of glutathione levels by the flavonoid fisetin. Biochem Pharmacol. 85:1816–1826. 2013. View Article : Google Scholar : PubMed/NCBI
45	Dickhout JG, Carlisle RE, Jerome DE, et al: Integrated stress response modulates cellular redox state via induction of cystathionine gamma-lyase: cross-talk between integrated stress response and thiol metabolism. J Biol Chem. 287:7603–7614. 2012. View Article : Google Scholar : PubMed/NCBI
46	Yang BC, Wang YS, Liu HS and Lin SJ: Ras signaling is involved in the expression of Fas-L in glioma. Lab Invest. 80:529–537. 2000. View Article : Google Scholar : PubMed/NCBI
47	Bermano G, Smyth E, Goua M, Heys SD and Wahle KW: Impaired expression of glutathione peroxidase-4 gene in peripheral blood mononuclear cells: a biomarker of increased breast cancer risk. Cancer Biomark. 7:39–46. 2010.PubMed/NCBI
48	Schneider M, Wortmann M, Mandal PK, et al: Absence of Absence of glutathione peroxidase 4 affects tumor angiogenesis through increased 12/15-lipoxygenase activity. Neoplasia. 12:254–263. 2010.PubMed/NCBI